There’s a New Covid-19 Variant and Cases Are Ticking Up. What Do You Need to Know?
The covid-19 virus is continually changing, and a recent subvariant, the JN.1, is rapidly climbing the charts.
The independent source for health policy research, polling, and news.
541 - 560 of 3,672 Results
The covid-19 virus is continually changing, and a recent subvariant, the JN.1, is rapidly climbing the charts.
KFF Health News and California Healthline staffers made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
The Biden administration is allowing states to use money from the insurance program for low-income and disabled residents to pay for gun violence prevention. California and six other states have approved such spending, with more expected to follow.
Only a few states have rules to protect workers from the growing threat of extreme heat, either indoors or outdoors. California is expected to adopt heat standards for indoor workers in spring, even as federal legislation has stalled.
Debate and speculation are heating up over whether Robert F. Kennedy Jr.’s presidential campaign will factor into the outcome of the 2024 election. But one thing is clear: Kennedy’s political following is built on a movement that seeks to legitimize conspiracy theories.
2023 was another busy year in health care. As the covid-19 pandemic waned, policymakers looked anew at long-standing obstacles to obtaining and paying for care in the nation’s health care system. Meanwhile, abortion has continued to be an issue in much of the nation, as states respond to the Supreme Court’s 2022 decision overturning the constitutional right to the procedure. This week, Rachel Cohrs of Stat, Sandhya Raman of CQ Roll Call, and Joanne Kenen of Johns Hopkins University and Politico Magazine join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and wrap up the year in health. Also this week, Rovner interviews KFF Health News’ Jordan Rau about his joint KFF Health News-New York Times series “Dying Broke.”
In the past year, opioid settlement money has gone from an emerging funding stream for which people had lofty but uncertain aspirations to a coveted pot of billions being invested in remediation efforts. Here are some important and evolving factors to watch going forward.
Cost estimates balloon and complications mount as the Defense Department grapples with PFAS pollution at hundreds of its bases and surrounding communities.
Federal officials issued their first guidelines on preparing morel mushrooms after a deadly food poisoning outbreak in Montana, noting the toxins in the delicacy aren’t fully understood.
As opioid settlement dollars land in government coffers, a swarm of businesses are positioning themselves to profit from the windfall. But will their potential gains come at the expense of the settlements’ intended purpose — to remediate the effects of the opioid epidemic?
The Supreme Court agreed this week to hear its first major case on abortion since overturning Roe v. Wade — one that could restrict the availability of the abortion pill mifepristone, even in states where abortion remains legal. Meanwhile, on Capitol Hill, lawmakers in the House and Senate finally moved to renew health programs that expired in October — but it’s likely too late to finish the job in 2023. Alice Miranda Ollstein of Politico, Riley Griffin of Bloomberg News, and Lauren Weber of The Washington Post join KFF Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Jen Golbeck, a University of Maryland professor and social media superstar, about her new book, “The Purest Bond,” which lays out the science of the human-canine relationship.
The Centers for Disease Control and Prevention is considering fuzzy guidelines on infection control in hospitals, critics say, leaving employers free to cut corners on N95 masks and other protective measures.
KFF Health News and California Healthline staffers made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
Peer-to-peer efforts can meet a clear need among students whose colleges may not make sexual health products accessible or affordable.
KFF Health News gives readers a chance to comment on a recent batch of stories.
The Supreme Court heard arguments over whether the Sacklers, the family behind Purdue Pharma — which marketed OxyContin — could claim immunity from future lawsuits without claiming bankruptcy.
The two governors exchanged heated verbal barbs when they faced off in a wide-ranging debate that covered various health-related topics, from abortion to gun violence.
At least 17 states have issued PFAS-related fish consumption advisories, KFF Health News found. But with no federal guidance, what is considered safe to eat varies significantly among states, most of which provide no regulation.
© 2026 KFF